These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7542970)
21. Laser treatment of the prostate using the Urolase fiber: the Dutch experience. te Slaa E; Mooibroek JJ; de Reijke TM; Karthaus HF; van Capelle JW; Gi NT; de la Rosette JJ J Urol; 1996 Aug; 156(2 Pt 1):420-4; discussion 425. PubMed ID: 8683693 [TBL] [Abstract][Full Text] [Related]
22. Local anesthesia for laser prostatectomy. Leach GE J Endourol; 1995 Apr; 9(2):159-61. PubMed ID: 7543326 [TBL] [Abstract][Full Text] [Related]
24. Free-beam and contact laser ablation of benign prostatic hyperplasia with the KTP/Nd:YAG laser: efficacy and versatility. Manyak MJ; Aulisi GP World J Urol; 1995; 13(2):104-8. PubMed ID: 7542961 [TBL] [Abstract][Full Text] [Related]
25. Comparison of germanium oxide fibers with silica and sapphire fiber tips for transmission of erbium: YAG laser radiation. Polletto TJ; Ngo AK; Tchapyjnikov A; Levin K; Tran D; Fried NM Lasers Surg Med; 2006 Sep; 38(8):787-91. PubMed ID: 16988959 [TBL] [Abstract][Full Text] [Related]
26. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Anson K; Nawrocki J; Buckley J; Fowler C; Kirby R; Lawrence W; Paterson P; Watson G Urology; 1995 Sep; 46(3):305-10. PubMed ID: 7544932 [TBL] [Abstract][Full Text] [Related]
27. Laser prostatectomy for patients with benign prostatic hyperplasia: a prospective randomized study comparing two different techniques using the Prolase-II fiber. Boon TA; van Swol CF; van Venrooij GE; Beerlage HP; Verdaasdonk RM World J Urol; 1995; 13(2):123-5. PubMed ID: 7542965 [TBL] [Abstract][Full Text] [Related]
28. Laser ablation of the prostate. Dixon CM; Lepor H Semin Urol; 1992 Nov; 10(4):273-7. PubMed ID: 1283026 [No Abstract] [Full Text] [Related]
29. Visual laser ablation of the canine prostate with a diffusing fiber and an 805-nanometer diode laser. Cromeens DM; Johnson DE; Stephens LC; Gray KN Lasers Surg Med; 1996; 19(2):135-42. PubMed ID: 8887915 [TBL] [Abstract][Full Text] [Related]
30. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Sengör F; Köse O; Yücebas E; Beysel M; Erdogan K; Narter F Br J Urol; 1996 Sep; 78(3):398-400. PubMed ID: 8881949 [TBL] [Abstract][Full Text] [Related]
31. Dosimetry studies utilizing the urolase right-angle firing neodymium:YAG laser fiber in the human prostate. Kabalin JN; Terris MK; Mancianti ML; Fajardo LF Lasers Surg Med; 1996; 18(1):72-80. PubMed ID: 8850468 [TBL] [Abstract][Full Text] [Related]
32. Factors affecting size and configuration of neodymium:YAG (Nd:YAG) laser lesions in the prostate. Fournier GR; Narayan P Lasers Surg Med; 1994; 14(4):314-22. PubMed ID: 7521504 [TBL] [Abstract][Full Text] [Related]